Sanofi restructures US commercial vaccines sales force
Sanofi is overhauling its US commercial operations for its vaccines and will cut an undisclosed number of jobs, the company confirmed to Endpoints News. The move follows some big R&D changes in CEO Paul Hudson’s push to start a new chapter at the French pharma. Hudson has set out to